Skip to main content
SpringerLink
Log in

Human and animal studies of schizophrenia-related gating deficits

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

Prepulse Inhibition (PPI) of the startle response and the P50 auditory-evoked potential suppression are used to assess impairments in the regulation of the neural substrates and to determine the clinical significance of inhibitory deficits in schizophrenia. The study of gating deficits in schizophrenia and in related animal model studies have already advanced our understanding of the neural substrates of information processing abnormalities in patients with schizophrenia. Individuals with schizotypal personality disorder as well as clinically unaffected family members of patients with schizophrenia show PPI and P50 suppression deficits. These "schizophrenic spectrum" populations are not grossly psychotic, nor are they receiving antipsychotic medications. Therefore, the gating deficits are presumed to reflect core (eg, intermediate phenotypic) schizophrenialinked information processing abnormalities. Several studies have reported that gating deficits are associated with clinical ratings of psychiatric symptoms, thought disorder, and neuropsychologic deficits in patients with schizophrenia. In addition, recent human pharmacologic studies have indicated that gating deficits can be reversed by rationallyselected compounds. Animal model studies have generally shown convergence with the human studies and may lead to improved identification of efficacious new antipsychotic medications for patients with schizophrenia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Kraepelin E: Dementia praecox and paraphrenia. Edinburgh: Livingstone; 1919.

    Google Scholar 

  2. Bleuler E: Dementia praecox, oder Gruppe der Schizophrenien. Leipzig: F. Deuticke; 1911.

    Google Scholar 

  3. McGhie A, Chapman J: Disorders of attention and perception in early schizophrenia. Brit J Med Psychol 1961, 103–116.

  4. Braff DL: Psychophysiological and information processing approaches to schizophrenia, in Neurobiological Foundation of Mental Illness. Edited by Charney DS, Nestler E, Bunney BS. New York: Oxford University Press; 1999. A general review of the attentional and information processing deficits in schizophrenia spectrum populations.

    Google Scholar 

  5. Braff DL, Swerdlow NR, Geyer MA: Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. Am J Psychiatry 1999, 156(4):596–602.

    PubMed  CAS  Google Scholar 

  6. Braff D, Stone C, Callaway E, et al.: Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 1978, 15(4):339–343.

    Article  PubMed  CAS  Google Scholar 

  7. Grillon C, Ameli R, Charney DS, et al.: Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol Psychiatry 1992, 32(10):939–943.

    Article  PubMed  CAS  Google Scholar 

  8. Bolino F, Di Michele V, Di Cicco L, et al.: Sensorimotor gating and habituation evoked by electro-cutaneous stimulation in schizophrenia. Biol Psychiatry 1994, 36(10):670–679.

    Article  PubMed  CAS  Google Scholar 

  9. Boutros NN, Zouridakis G, Overall J: Replication and extension of P50 findings in schizophrenia. Clin Electroencephalogr 1991, 22(1):40–45.

    PubMed  CAS  Google Scholar 

  10. Clementz BA, Geyer MA, Braff DL: P50 suppression among schizophrenia and normal comparison subjects: a methodological analysis. Biol Psychiatry 1997, 41(10):1035–1044.

    Article  PubMed  CAS  Google Scholar 

  11. Clementz BA, Geyer MA, Braff DL: Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects. Schizophr Res 1998, 30(1):71–80.

    Article  PubMed  CAS  Google Scholar 

  12. Clementz BA, Geyer MA, Braff DL: Poor P50 suppression among schizophrenia patients and their first-degree biological relatives. Am J Psychiatry 1998, 155(12):1691–1694. The first independent replication of reduced P50 suppression in clinically unaffected family members of patients with schizophrenia.

    PubMed  CAS  Google Scholar 

  13. Erwin RJ, Mawhinney-Hee M, Gur RC, et al.: Midlatency auditory evoked responses in schizophrenia. Biol Psychiatry 1991, 30(5):430–442.

    Article  PubMed  CAS  Google Scholar 

  14. Freedman R, Adler LE, Myles-Worsley M, et al.: Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects. Human recordings, computer simulation, and an animal model. Arch Gen Psychiatry 1996, 53(12):1114–1121.

    PubMed  CAS  Google Scholar 

  15. Griffith JM, O’Neill JE, Petty F, et al.: Nicotinic receptor desensitization and sensory gating deficits in schizophrenia. Biol Psychiatry 1998, 44(2):98–106.

    Article  PubMed  CAS  Google Scholar 

  16. Jin Y, Potkin SG, Patterson JV, et al.: Effects of P50 temporal variability on sensory gating in schizophrenia. Psychiatry Res 1997, 70(2):71–81.

    Article  PubMed  CAS  Google Scholar 

  17. Judd LL, McAdams L, Budnick B, et al.: Sensory gating deficits in schizophrenia: new results. Am J Psychiatry 1992, 149(4):488–493.

    PubMed  CAS  Google Scholar 

  18. Light GA, Geyer MA, Clementz BA, et al.: Schizophrenia patients treated with atypical antipsychotic medications have "normal" P50 suppression. In submission.: update?

  19. Nagamoto HT, Adler LE, Waldo MC, et al.: Sensory gating in schizophrenics and normal controls: effects of changing stimulation interval. Biol Psychiatry 1989, 25(5):549–561.

    Article  PubMed  CAS  Google Scholar 

  20. Ward PB, Hoffer LD, Liebert BJ, et al.: Replication of a P50 auditory gating deficit in Australian patients with schizophrenia. Psychiatry Res 1996, 64(2):121–135.

    Article  PubMed  CAS  Google Scholar 

  21. Perry W, Geyer MA, Braff DL: Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients. Arch Gen Psychiatry 1999, 56(3):277–281.This study reported that gating deficits (PPI) are highly correlated with thought disorder. Rorschach-derived measures of perceptual inaccuracies accounted for 60% of the variance in PPI, 35% above and beyond the effects attributable to clinical ratings of psychiatric symptoms.

    Article  PubMed  CAS  Google Scholar 

  22. Cadenhead KS, Carasso BS, Swerdlow NR, et al.: Prepulse inhibition and habituation of the startle response are stable neurobiological measures in a normal male population. Biol Psychiatry 1999, 45(3):360–364.

    Article  PubMed  CAS  Google Scholar 

  23. Geyer MA, Swerdlow NR: Multiple transmitters modulate prepulse inhibition of startle: Relevance to schizophrenia, in Interactive monoaminergic disorders. Edited by Palomo T, Beninger RJ, Archer T. Madrid: Editorial Sintesis, SA; 1999.

    Google Scholar 

  24. Swerdlow NR, Geyer MA: Neurophysiology and neuropharmacology of short lead interval startle modification, in Startle modification: Implications for neuroscience, cognitive science, and clinical science. Edited by Dawson ME, Schell AM, Bohmelt AH. Cambridge: Cambridge University Press; 1999.

    Google Scholar 

  25. Swerdlow NR, Braff DL, Geyer MA: Cross-species studies of sensorimotor gating of the startle reflex. Ann N Y Acad Sci 1999, 877:202–216.

    Article  PubMed  CAS  Google Scholar 

  26. Davis M, Gendelman DS, Tischler MD, et al.: A primary acoustic startle circuit: lesion and stimulation studies. J Neurosci 1982, 2(6):791–805.

    PubMed  CAS  Google Scholar 

  27. Davis M: The mammalian startle response, in Neural mechanisms of startle behavior. Edited by Eaton RC. New York: Plenum Press; 1984.

    Google Scholar 

  28. Geyer MA, Markou A: Animal models of psychiatric disorders, in Psychopharmacology: The fourth generation of progress. Edited by Bloom FE, Kupfer DJ. New York: Raven Press; 1995.

    Google Scholar 

  29. Swerdlow NR, Geyer MA: Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophrenia Bulletin 1998, 24(2):285–301.

    PubMed  CAS  Google Scholar 

  30. Swerdlow NR, Taaid N, Oostwegel JL, et al.: Towards a crossspecies pharmacology of sensorimotor gating: effects of amantadine, bromocriptine, pergolide and ropinirole on prepulse inhibition of acoustic startle in rats. Behav Pharmacol 1998, 9(5-6):389–396.

    Article  PubMed  CAS  Google Scholar 

  31. Swerdlow NR, Geyer MA: Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 1998, 24(2):285–301.

    PubMed  CAS  Google Scholar 

  32. Swerdlow NR, Braff DL, Taaid N, et al.: Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Archives of General Psychiatry 1994, 51(2):139–154.

    PubMed  CAS  Google Scholar 

  33. Geyer MA: Behavioral studies of hallucinogenic drugs in animals: implications for schizophrenia research. Pharmacopsychiatry 1998, 31(Suppl 2):73–79.

    PubMed  CAS  Google Scholar 

  34. Geyer MA, Braff DL: Startle habituation and sensorimotor gating in schizophrenia and related animal models. Schizophr Bull 1987, 13(4):643–668.

    PubMed  CAS  Google Scholar 

  35. Braff DL, Geyer MA: Sensorimotor gating and schizophrenia: Human and animal model studies. Archives of General Psychiatry 1990, 47(2):181–188.

    PubMed  CAS  Google Scholar 

  36. Hoffman HS, Searle JL: Acoustic and temporal factors in the evocation of startle. J Acoust Soc Am 1968, 43(2):269–282.

    Article  PubMed  CAS  Google Scholar 

  37. Ison JR, McAdam DW, Hammond GR: Latency and amplitude changes in the acoustic startle reflex of the rat produced by variation in auditory prestimulation. Physiol Behav 1973, 10(6):1035–1039.

    Article  PubMed  CAS  Google Scholar 

  38. Graham FK: Presidential Address, 1974. The more or less startling effects of weak prestimulation. Psychophysiology 1975, 12(3):238–248.

    Article  PubMed  CAS  Google Scholar 

  39. Geyer MA, Braff DL, Swerdlow NR: Startle response measures of information processing in animals: Relevance to schizophrenia, in Animal models of human emotion and cognition, 1st edn. Edited by Haug M, Whalen RE. Washington, DC: American Psychological Association; 1999.

    Google Scholar 

  40. Swerdlow NR, Benbow CH, Zisook S, et al.: A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol Psychiatry 1993, 33(4):298–301.

    Article  PubMed  CAS  Google Scholar 

  41. Swerdlow NR, Paulsen J, Braff DL, et al.: Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington’s disease. J Neurol Neurosurg Psychiatry 1995, 58(2):192–200.

    Article  PubMed  CAS  Google Scholar 

  42. Ornitz EM, Russell AT, Hanna GL, et al.: Prepulse inhibition of startle and the neurobiology of primary nocturnal enuresis. Biol Psychiatry 1999, 45(11):1455–1466.

    Article  PubMed  CAS  Google Scholar 

  43. Ornitz EM, Hanna GL, de Traversay J: Prestimulation-induced startle modulation in attention-deficit hyperactivity disorder and nocturnal enuresis. Psychophysiology 1992, 29(4):437–451.

    Article  PubMed  CAS  Google Scholar 

  44. Castellanos FX, Fine EJ, Kaysen D, et al.: Sensorimotor gating in boys with Tourette’s syndrome and ADHD: preliminary results. Biol Psychiatry 1996, 39(1):33–41.

    Article  PubMed  CAS  Google Scholar 

  45. Swerdlow NR, Koob GF: Dopamine, schizophrenia, mania, and depression: Toward a unified hypothesis of cortico-striato-pallido-thalamic function. Behavioral & Brain Sciences 1987, 10(2):197–245.

    Article  Google Scholar 

  46. Eccles JC: The inhibitory pathways of the central nervous system. Springfield: Thomas; 1969.

    Google Scholar 

  47. Davis H, Mast T, Yoshie N, et al.: The slow response of the human cortex to auditory stimuli: recovery process. Electroencephalogr Clin Neurophysiol 1966, 21(2):105–113.

    Article  PubMed  CAS  Google Scholar 

  48. Adler LE, Pachtman E, Franks RD, et al.: Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry 1982, 17(6):639–654.

    PubMed  CAS  Google Scholar 

  49. Adler LE, Freedman R, Ross RG, et al.: Elementary phenotypes in the neurobiological and genetic study of schizophrenia. Biol Psychiatry 1999, 46(1):8–18.

    Article  PubMed  CAS  Google Scholar 

  50. Adler LE, Olincy A, Waldo M, et al.: Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull 1998, 24(2):189–202.

    PubMed  CAS  Google Scholar 

  51. Franks RD, Adler LE, Waldo MC, et al.: Neurophysiological studies of sensory gating in mania: comparison with schizophrenia. Biol Psychiatry 1983, 18(9):989–1005.

    PubMed  CAS  Google Scholar 

  52. Baker NJ, Staunton M, Adler LE, et al.: Sensory gating deficits in psychiatric inpatients: relation to catecholamine metabolites in different diagnostic groups. Biol Psychiatry 1990, 27(5):519–528.

    Article  PubMed  CAS  Google Scholar 

  53. Bickford-Wimer PC, Nagamoto H, Johnson R, et al.: Auditory sensory gating in hippocampal neurons: a model system in the rat. Biol Psychiatry 1990, 27(2):183–192.

    Article  PubMed  CAS  Google Scholar 

  54. Luntz-Leybman V, Bickford PC, Freedman R: Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res 1992, 587(1):130–136.

    Article  PubMed  CAS  Google Scholar 

  55. Stevens KE, Nagamoto H, Johnson RG, et al.: Kainic acid lesions in adult rats as a model of schizophrenia: changes in auditory information processing. Neuroscience 1998, 82(3):701–708.

    Article  PubMed  CAS  Google Scholar 

  56. Cadenhead KS, Geyer MA, Braff DL: Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. Am J Psychiatry 1993, 150(12):1862–1867.

    PubMed  CAS  Google Scholar 

  57. Cadenhead KS, Light GA, Geyer MA, et al.: P50 Sensory Gating Deficits in Schizotypal Subjects. In submission.: update?.

  58. Cadenhead KS, Geyer MA, Swerdlow NR, et al.: Prepulse inhibition and laterality in schizophrenic patients and their relatives, in Schizophrenia Research 1999, 36:252.

    Google Scholar 

  59. Adler LE, Hoffer LJ, Griffith J, et al.: Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol Psychiatry 1992, 32(7):607–616.

    Article  PubMed  CAS  Google Scholar 

  60. Freedman R, Coon H, Myles-Worsley M, et al.: Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci U S A 1997, 94(2):587–592.

    Article  PubMed  CAS  Google Scholar 

  61. Siegel C, Waldo M, Mizner G, et al.: Deficits in sensory gating in schizophrenic patients and their relatives. Evidence obtained with auditory evoked responses. Arch Gen Psychiatry 1984, 41(6):607–612.

    PubMed  CAS  Google Scholar 

  62. Waldo MC, Carey G, Myles-Worsley M, et al.: Codistribution of a sensory gating deficit and schizophrenia in multi-affected families. Psychiatry Res 1991, 39(3):257–268.

    Article  PubMed  CAS  Google Scholar 

  63. Waldo M, Myles-Worsley M, Madison A, et al.: Sensory gating deficits in parents of schizophrenics. Am J Med Genet 1995, 60(6):506–511.

    Article  PubMed  CAS  Google Scholar 

  64. Kumari V, Soni W, Sharma T: Clozapine normalizes information processing deficits in schizophrenia. Am J Psychiatry 1999, in press.

  65. Nagamoto HT, Adler LE, Hea RA, et al.: Gating of auditory P50 in schizophrenics: unique effects of clozapine. Biol Psychiatry 1996, 40(3):181–188.

    Article  PubMed  CAS  Google Scholar 

  66. Nagamoto HT, Adler LE, McRae KA, et al.: Auditory P50 in schizophrenics on clozapine: improved gating parallels clinical improvement and changes in plasma 3-methoxy-4-hydroxyphenylglycol. Neuropsychobiology 1999, 39(1):10–17. This is a report of clozapine normalizing P50 suppression deficits in treatment refractory patients with schizophrenia using a longitudinal, within-subjects design. Clozapine’s normalizing effect on P50 suppression lasted throughout the 15-month study period and the improvements were correlated with a noradrenergic metabolite.

    Article  PubMed  CAS  Google Scholar 

  67. Yee CM, Nuechterlein KH, Morris SE, et al.: P50 suppression in recent-onset schizophrenia: clinical correlates and risperidone effects. J Abnorm Psychol 1998, 107(4):691–698.

    Article  PubMed  CAS  Google Scholar 

  68. Butler RW, Jenkins MA, Geyer MA, et al.: Wisconsin Card Sorting deficits and diminished sensorimotor gating in a discrete subgroup of schizophrenic patients, in Schizophrenia Research. Edited by Tamminga CA, Schulz SC, et al. New York:Raven Press; 1991.

    Google Scholar 

  69. Karper LP, Freeman GK, Grillon C, et al.: Preliminary evidence of an association between sensorimotor gating and distractibility in psychosis. J Neuropsychiatry Clin Neurosci 1996, 8(1):60–66.

    PubMed  CAS  Google Scholar 

  70. Perry W, Braff DL: Information-processing deficits and thought disorder in schizophrenia. Am J Psychiatry 1994, 151(3):363–367.

    PubMed  CAS  Google Scholar 

  71. Cullum CM, Harris JG, Waldo MC, et al.: Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia. Schizophr Res 1993, 10(2):131–141.

    Article  PubMed  CAS  Google Scholar 

  72. Erwin RJ, Turetsky BI, Moberg P, et al.: P50 abnormalities in schizophrenia: relationship to clinical and neuropsychological indices of attention. Schizophr Res 1998, 33(3):157–167.

    Article  PubMed  CAS  Google Scholar 

  73. Hughes JR, Hatsukami DK, Mitchell JE, et al.: Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 1986, 143(8):993–997.

    PubMed  CAS  Google Scholar 

  74. Adler LE, Hoffer LD, Wiser A, et al.: Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry 1993, 150(12):1856–1861.

    PubMed  CAS  Google Scholar 

  75. Stevens KE, Freedman R, Collins AC, et al.: Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Neuropsychopharmacology 1996, 15(2):152–162.

    Article  PubMed  CAS  Google Scholar 

  76. Bickford PC, Wear KD: Restoration of sensory gating of auditory evoked response by nicotine in fimbria-fornix lesioned rats. Brain Res 1995, 705(1-2):235–240.

    Article  PubMed  CAS  Google Scholar 

  77. Stevens KE, Wear KD: Normalizing effects of nicotine and a novel nicotinic agonist on hippocampal auditory gating in two animal models. Pharmacol Biochem Behav 1997, 57(4):869–874.

    Article  PubMed  CAS  Google Scholar 

  78. Adams CE, Stevens KE: Inhibition of nitric oxide synthase disrupts inhibitory gating of auditory responses in rat hippocampus. J Pharmacol Exp Ther 1998, 287(2):760–765. This study reported that stimulation of nicotinic receptors releases nitric oxide. The authors offer an explanation for why the behavioral effects of nicotine (on suppression deficits) have a longer time course that would be expected given the relatively rapid desensitization of nicotinic receptors.

    PubMed  CAS  Google Scholar 

  79. Adams CE, Stevens KE, Kem WR, et al.: Inhibition of nitric oxide synthase prevents alpha 7 nicotinic receptor-mediated restoration of inhibitory auditory gating in rat hippocampus. In submission.

  80. Kumari V, Checkley SA, Gray JA: Effect of cigarette smoking on prepulse inhibition of the acoustic startle reflex in healthy male smokers. Psychopharmacology (Berl) 1996, 128(1):54–60.

    Article  CAS  Google Scholar 

  81. Clarke PB, Pert CB, Pert A: Autoradiographic distribution of nicotine receptors in rat brain. Brain Res 1984, 323(2):390–395.

    Article  PubMed  CAS  Google Scholar 

  82. Swerdlow NR, Caine SB, Geyer MA: Regionally selective effects of intracerebral dopamine infusion on sensorimotor gating of the startle reflex in rats. Psychopharmacology (Berl) 1992, 108(1-2):189–195.

    Article  CAS  Google Scholar 

  83. Jones GM, Sahakian BJ, Levy R, et al.: Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer’s disease. Psychopharmacology 1992, 108(4):485–494.

    Article  PubMed  CAS  Google Scholar 

  84. Kumari V, Cotter PA, Checkley SA, et al.: Effect of acute subcutaneous nicotine on prepulse inhibition of the acoustic startle reflex in healthy male non-smokers. Psychopharmacology (Berl) 1997, 132(4):389–395.

    Article  CAS  Google Scholar 

  85. Abduljawad KA, Langley RW, Bradshaw CM, et al.: Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle eyeblink response in man. J Psychopharmacol 1998, 12(1):239–245.

    Article  PubMed  CAS  Google Scholar 

  86. Ellenbroek BA, Budde S, Cools AR: Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex. Neuroscience 1996, 75(2):535–542.

    Article  PubMed  CAS  Google Scholar 

  87. Varty GB, Higgins GA: Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs. Psychopharmacology (Berl) 1995, 122(1):15–26.

    Article  CAS  Google Scholar 

  88. Swerdlow NR, Vaccarino FJ, Amalric M, et al.: The neural substrates for the motor-activating properties of psychostimulants: a review of recent findings. Pharmacol Biochem Behav 1986, 25(1):233–248.

    Article  PubMed  CAS  Google Scholar 

  89. Campeau S, Davis M: Prepulse inhibition of the acoustic startle reflex using visual and auditory prepulses: disruption by apomorphine. Psychopharmacology (Berl) 1995, 117(3):267–274.

    Article  CAS  Google Scholar 

  90. Mansbach RS, Geyer MA, Braff DL: Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 1988, 94(4):507–514.

    Article  PubMed  CAS  Google Scholar 

  91. Swerdlow NR, Mansbach RS, Geyer MA, et al.: Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology 1990, 100(3):413–416.

    Article  PubMed  CAS  Google Scholar 

  92. Druhan JP, Geyer MA, Valentino RJ: Lack of sensitization to the effects of d-amphetamine and apomorphine on sensorimotor gating in rats. Psychopharmacology (Berl) 1998, 135(3):296–304.

    Article  CAS  Google Scholar 

  93. Ralph RJ, Varty GB, Kelly MA, et al.: The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. J Neurosci 1999, 19(11):4627–4633.

    PubMed  CAS  Google Scholar 

  94. Adler LE, Rose G, Freedman R: Neurophysiological studies of sensory gating in rats: effects of amphetamine, phencyclidine, and haloperidol. Biol Psychiatry 1986, 21(8-9):787–798.

    Article  PubMed  CAS  Google Scholar 

  95. Adler LE, Pang K, Gerhardt G, et al.: Modulation of the gating of auditory evoked potentials by norepinephrine: pharmacological evidence obtained using a selective neurotoxin. Biol Psychiatry 1988, 24(2):179–190.

    Article  PubMed  CAS  Google Scholar 

  96. Johnson RG, Stevens KE, Rose GM: 5-Hydroxytryptamine2 receptors modulate auditory filtering in the rat. J Pharmacol Exp Ther 1998, 285(2):643–650.

    PubMed  CAS  Google Scholar 

  97. Stevens KE, Fuller LL, Rose GM: Dopaminergic and noradrenergic modulation of amphetamine-induced changes in auditory gating. Brain Res 1991, 555(1):91–98.

    Article  PubMed  CAS  Google Scholar 

  98. Stevens KE, Meltzer J, Rose GM: Disruption of sensory gating by the alpha 2 selective noradrenergic antagonist yohimbine. Biol Psychiatry 1993, 33(2):130–132.

    Article  PubMed  CAS  Google Scholar 

  99. Stevens KE, Luthman J, Lindqvist E, et al.: Effects of neonatal dopamine depletion on sensory inhibition in the rat. Pharmacol Biochem Behav 1996, 53(4):817–823.

    Article  PubMed  CAS  Google Scholar 

  100. Light GA, Malaspina DM, Geyer MA, et al.: Amphetamine disrupts P50 suppression in normal subjects. Biol Psychiatry 1999, in press.

  101. van Berckel BN, Oranje B, van Ree JM, et al.: The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects. Psychopharmacology (Berl) 1998, 137(3):271–281.

    Article  Google Scholar 

  102. de Bruin NM, Ellenbroek BA, Cools AR, et al.: Differential effects of ketamine on gating of auditory evoked potentials and prepulse inhibition in rats. Psychopharmacology (Berl) 1999, 142(1):9–17.

    Article  Google Scholar 

  103. Geyer MA, Wilkinson LS, Humby T, et al.: Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia. Biol Psychiatry 1993, 34(6):361–372.

    Article  PubMed  CAS  Google Scholar 

  104. Bakshi VP, Swerdlow NR, Braff DL, et al.: Reversal of isolation rearing-induced deficits in prepulse inhibition by Seroquel and olanzapine. Biol Psychiatry 1998, 43(6):436–445.

    Article  PubMed  CAS  Google Scholar 

  105. Stevens KE, Johnson RG, Rose GM: Rats reared in social isolation show schizophrenia-like changes in auditory gating. Pharmacol Biochem Behav 1997, 58(4):1031–1036.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of California, San Diego, 9500 Gilman Drive, 92093-0804, La Jolla, CA, USA

    Gregory A. Light BA & David L. Braff MD

Authors
  1. Gregory A. Light BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David L. Braff MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Light, G.A., Braff, D.L. Human and animal studies of schizophrenia-related gating deficits. Curr Psychiatry Rep 1, 31–40 (1999). https://doi.org/10.1007/s11920-999-0008-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-999-0008-y

Keywords

Search

Navigation